Marketed in the past by AstraZeneca as Pulmicort, budesonide is an off-patent inhaled steroid and could be used ... with asthma or chronic obstructive pulmonary disease (COPD) were surprisingly ...

Methods Using gene set variation analysis, we examined the distribution and enrichment scores (ES) of the 3 TACs in the transcriptome of bronchial biopsies from 46 patients who participated in the ...

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...

During and after an exacerbation, mental recovery involves taking care of both your physical and mental health. Resting, ...

In today’s fast-paced world, respiratory issues have become increasingly common, affecting individuals of all ages. Whether it’s due to environmental pollutants, allergens, or chronic conditions like ...

After decades of cumulative experience with countless patients, we can testify that no other medications can compete with corticosteroids for giving immediate improvement of this condition.

This helps your provider determine which medications to use to ... you may need to take steroids or oxygen. The treatment options for stage 3 COPD are similar to stage 2. You’re more likely ...

Chronic obstructive pulmonary disease (COPD), a condition that affects more than 14 million U.S. adults, is marked by damage ...

Purpose. Special considerations in the selection of medication inhaler devices for elderly patients with chronic obstructive pulmonary disease (COPD) in the ambulatory care setting are reviewed.

UnitedHealth's pharmacy benefit manager (PBM), after it upped the price of his steroid inhaler from $66 to $539. In their suit, Shanon and William Schmidtknect allege that Optum operates as part ...